Aviceda Therapeutics

0 followers


Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

Industries

Headquarters

Stage

Employees

Links

Org chart

Mohamed A. Genead
Co-Founder, CEO & Chairman

Mohamed A. Genead

Collapse
David Callanan
SVP & Chief Medical Officer
Derek Kunimoto
Co-Founder & Chief Strategy Officer
Michael Tolentino
Co-Founder, CTO
Tarek S. Hassan
SVP & Chief Development Officer
Cheryl L. Rowe-Rendleman
SVP, Head of Regulatory Affairs
Mike Guo
SVP, Business Development & Corporate Strategy
Anitha Krishnan
Head of Biology Research
Amitkumar Lad
Director, Nano-Formulations and Analytical Development (CMC-Head)
Sunny Christian
Senior Manager